SIA "Orthos Pharma"
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2023-08-21
Change in beneficial owners2023-08-21
Change in members2023-08-21
Change in officers2023-08-04
Unidentified type of changeSuspensions
No suspension
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
46Debts
0.00 €
0 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
0
Credit limit
***** €
Turnover
20-50 M €
+44.82 %Business linkages
6Linkages with other companies
Financial ratios
Net Profit (€)
838,216
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
838,216EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2023 |
|---|
| 15,560,557 |
| 707,298 |
| 621,407 |
| 621,407 |
| 28,246 |
| 30.35 |
| 3.99 |
| 3,653,292 |
| 3,148,798 |
| 4,531 |
| 6,797,559 |
| 2024 |
|---|
| 20,305,642 |
| 483,468 |
| 1,149,625 |
| 1,149,625 |
| 27,372 |
| 27.92 |
| 5.66 |
| 4,802,917 |
| 3,553,774 |
| 13,292 |
| 8,343,399 |
| 2025 |
|---|
| 29,407,217 |
| 639,287 |
| 838,216 |
| 838,216 |
| 18,222 |
| 35.99 |
| 2.85 |
| 5,641,133 |
| 6,887,040 |
| 25,776 |
| 12,502,397 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 29,407,217 |
| 639,287 |
| 838,216 |
| 838,216 |
| 18,222 |
| 35.99 |
| 2.85 |
| 5,641,133 |
| 6,887,040 |
| 25,776 |
| 12,502,397 |
Enjoy unlimited use
with Freemium unlimited2025
Turnover (€)
29,407,217 €
45 % *
Sales per employee (€)
639,287 €32 % *
Profit before tax (€)
838,216 €
-27 % *
Net Profit (€)
838,216 €-27 % *
Profit per employee (€)
18,222 €-33 % *
Total profitability (%)
35.99 %28.90 % *
Net profitability (%)
2.85 %-49.65 % *
Equity (€)
5,641,133 €17 % *
Amounts Payable And Liabilities (€)
6,887,040 €
94 % *
Non-current Assets (€)
25,776 €94 % *
Current Assets (€)
12,502,397 €50 % *
Credit history
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(0)
Plaintiff
(0)
SIA "Orthos Pharma" has no court cases
SIA "Orthos Pharma" has no registered court cases as defendant or plaintiff within the last 2 years.
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 128,170 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 126,360 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 134,630 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 145,930 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| Total amount: 1,940 |
Similar companies
Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40003996045Reg. date:
27/02/2008Turnover:
-No. of employees:
46Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
48503008960Reg. date:
29/10/2002Turnover:
-No. of employees:
55Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40003519061Reg. date:
20/11/2000Turnover:
-No. of employees:
48Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
50003399781Reg. date:
29/06/1998Turnover:
-No. of employees:
34Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40003395114Reg. date:
22/05/1998Turnover:
-No. of employees:
41Description
CopyAbout SIA "Orthos Pharma"
SIA "Orthos Pharma" is a registered company in Latvia. It was incorporated on 02/12/2014 and is registered under company number 50103850761. Its registered office is located at Ozolciema iela 18 – 338, Rīga, LV-1058. The company's registered activity is Wholesale of pharmaceutical products and medical supplies (46.46 - NACE 2.1).Frequently Asked Questions
What is the current status of SIA "Orthos Pharma"?
SIA "Orthos Pharma" is currently Registered. It was registered on 02/12/2014.
What is SIA "Orthos Pharma" registered address?
SIA "Orthos Pharma" registered address is Ozolciema iela 18 – 338, Rīga, LV-1058.
What is SIA "Orthos Pharma" activity?
SIA "Orthos Pharma" operates in Wholesale of pharmaceutical products and medical supplies (46.46 - NACE 2.1).
How many employees does SIA "Orthos Pharma" have?
SIA "Orthos Pharma" has 46 employees (2025).
Is SIA "Orthos Pharma" a reliable company?
SIA "Orthos Pharma" Pre-Score* rating is A, which indicates the highest level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.What is the annual turnover of SIA "Orthos Pharma"?
SIA "Orthos Pharma" reported a turnover of 29,407,217 EUR in 2025.
Does SIA "Orthos Pharma" have any current state debt?
SIA "Orthos Pharma" currently has no outstanding state debt.